Quantification of the major urinary metabolite of 15-F(2T)-isoprostane (8-iso-PGF(2α)) by a stable isotope dilution mass spectrometric assay

Analytical Biochemistry

Volumn 269, Issue 2, 1999, Pages 326-331

  Morrow, Jason D ^a   Zackert, William E ^a   Yang, James P ^a   Kurhts, Eric H ^b   Callewaert, Denis ^c   Dworski, Ryszard ^a   Kanai, Kazuo ^d   Taber, Douglass ^d   Moore, Kevin ^e   Oates, John A ^a   Roberts, L Jackson ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b Lipoprotein Technologies Inc   (United States)

^c OAKLAND UNIVERSITY   (United States)

^d UNIVERSITY OF DELAWARE   (United States)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Eicosanoid; Isoprostane; Lipid; Metabolite; Oxidation; Prostaglandin

Indexed keywords

BIOACTIVITY; BIOMOLECULES; FREE RADICALS; GAS INDUSTRY; IONIZATION OF GASES; LIPIDS; MASS SPECTROMETRY; OXIDATION;

CHEMICAL IONIZATION MASS SPECTROMETRY; EICOSANOID; INTERNAL STANDARDS; ISOPROSTANES; PATHOPHYSIOLOGICAL; PROSTAGLANDIN; TRIMETHYLSILYL ETHERS; URINARY METABOLITES;

METABOLITES;

2,3 DINOR 5,6 DIHYDRO 8 ISOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; CARBON TETRACHLORIDE; FREE RADICAL; ISOPROSTANE DERIVATIVE; OXYGEN 18; PROSTAGLANDIN F2 ALPHA DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; ISOTOPE DILUTION ASSAY; LIPID PEROXIDATION; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; URINARY EXCRETION; URINE LEVEL; VALIDATION PROCESS;

ANIMALIA;

EID: 0345211536     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4008     Document Type: Article

References (20)

1. Harman D. Proc. Natl. Acad. Sci. USA. 78:1981;7124-7128.
2. Ames B. N. Science. 221:1983;1256-1264.
3. Southorn P. A., Powis G. Mayo Clin. Proc. 63:1988;390-408.
4. Halliwell B., Gutteridge J. M. C. Meth. Enzymol. 186:1990;1-85.
5. Morrow J. D., Hill K. E., Burk R. F., Nammour T. M., Badr K. F., Roberts L. J. II. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387.
6. Morrow J. D., Harris T. M., Roberts L. J. II. Anal. Biochem. 184:1990;1-10.
7. Morrow J. D., Minton T. A., Badr K. F., Roberts L. J. II. Biochim. Biophys. Acta. 1210:1994;244-248.
8. Morrow J. D., Roberts L. J. II. Prog. Lipid Res. 36:1997;1-21.
9. Pryor W. A., Godber S. S. Free Rad. Biol. Med. 10:1991;173.
10. Catella F., Nowak J., Fitzgerald G. A. Am J. Med. 81:1986;23-29.
11. Morrow J. D., Moore K. P., Zackert W. E., Oates J. A., Roberts L. J. II. J. Biol. Chem. 271:1996;20617-20620.
12. Taber D. F., Herr R. J., Gleave D. M. J. Org. Chem. 62:1997;194-197.
13. Murphy R. C., Clay K. L. Methods Enzymol. 86:1982;547-551.
14. Davi G., Alessandrini P., Mezzetti A., Minotti G., Bucciarelli T., Costantini F., Cipollone F., Bon G. B., Ciabattoni G., Patrono C. Arterioscler. Thromb. Vasc. Biol. 17:1997;3230-3235.
15. Delanty N., Reilly M., Pratico D., Fitzgerald D. J., Lawson J. A., Fitzgerald G. A. Br. J. Clin. Pharmacol. 42:1996;15-19.
16. Roberts L. J. II. Handbook of Eicosanoids: Prostaglandins and Related Lipids: Chemical and Biochemical Aspects. 1987;CRC Press, Boca Raton. p. 233-244.
17. Patrono C., Fitzgerald G. A. Arterioscler. Thromb. Vasc. Biol. 17:1997;2309-2315.
18. Rokach J., Khanapure S. P., Hwang S-W., Adiyaman M., Lawson J. A., Fitzgerald G. A. Prostaglandins. 54:1997;823-851.
19. Frolich J. C., Wilson T. W., Sweetman B. J., Smigel M., Nies A. S., Carr K., Watson T., Oates J. A. J. Clin. Invest. 55:1975;763-770.
20. Salonen J. T. Arch. Toxicol. 20:1998;249-267.